Page last updated: 2024-09-05

ro 32-3555 and AIDS Seroconversion

ro 32-3555 has been researched along with AIDS Seroconversion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breen, R; D'Armiento, J; Edwards, DR; Elkington, P; Friedland, JS; Lipman, M; Mauri, F; Nuttall, RK; Pedersen, B; Robertson, BD; Saraiva, L; Shiomi, T; Ugarte-Gil, CA; Walker, NF	1

Other Studies

1 other study(ies) available for ro 32-3555 and AIDS Seroconversion

Article	Year
MMP-1 drives immunopathology in human tuberculosis and transgenic mice. The Journal of clinical investigation, 2011, Volume: 121, Issue:5 Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Movement; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; HIV Infections; HIV Seropositivity; Humans; Hydrogen-Ion Concentration; Imidazoles; Immune System; Matrix Metalloproteinase 1; Mice; Mice, Transgenic; Monocytes; Tuberculosis	2011

Article

Year

MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

The Journal of clinical investigation, 2011, Volume: 121, Issue:5

Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Movement; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; HIV Infections; HIV Seropositivity; Humans; Hydrogen-Ion Concentration; Imidazoles; Immune System; Matrix Metalloproteinase 1; Mice; Mice, Transgenic; Monocytes; Tuberculosis

2011